Latest news
Agenus Advances BOT+BAL in Neoadjuvant MSS Colon Cancer Through Phase 3 ROBBIN Trial - OncodailyOncodaily · Fri, 07 Aug 2026 08:38:45 GMTAgenus Reports Second Quarter 2026 Results and Advances Phase 3 ROBBIN Trial of BOT+BAL in Neoadjuvant MSS Colon Cancer - Yahoo Finance UKYahoo Finance UK · Thu, 06 Aug 2026 11:30:00 GMTAgenus advances Phase 3 ROBBIN trial of botensilimab-balstilimab in neoadjuvant MSS colon cancer - BitgetBitget · Thu, 06 Aug 2026 03:53:29 GMT